Abstract The butyrophilin 3 (BTN3) receptors are implicated in the T lymphocytes regulation and present a wide plasticity in mammals. In order to understand how these genes have been diversified, we studied their evolution and show that the three human BTN3 are the result of two successive duplications in Primates and that the three genes are present in Hominoids and the Old World Monkey groups. A thorough phylogenetic analysis reveals a concerted evolution of BTN3 characterized by a strong and recurrent homogenization of the region encoding the signal peptide and the immunoglobulin variable (IgV) domain in Hominoids, where the sequences of BTN3A1 or BTN3A3 are replaced by BTN3A2 sequence. In human, the analysis of the diversity of these genes in 1683 individuals representing 26 worldwide populations shows that the three genes are polymorphic, with more than 46 alleles for each gene, and marked by extreme homogenization of the IgV sequences. The same analysis performed for the BTN2 genes shows also a concerted evolution; however, it is not as strong and recurrent as for BTN3. This study shows that BTN3 receptors are marked by extreme concerted evolution at the IgV domain and that BTN3A2 plays a central role in this evolution.
Introduction
The butyrophilins 3 are receptors of the Immunoglobulins superfamily ubiquitously expressed on T and B lymphocytes, monocytes, natural killer (NK) cells, and dendritic cells (Compte et al. 2004; Messal et al. 2011; Yamashiro et al. 2010) . They form a group of three proteins BTN3A1, 3A2, and 3A3 with an extracellular region composed of two domains IgVand IgC (immunoglobulin constant) extremely conserved between the three proteins (Abeler-Dörner et al. 2012) but with a significant difference at the cytoplasmic region where BTN3A1 and 3A3 contain a B30.2 type domain which is absent in BTN3A2. BTN3 are butyrophilin family Laurent Abi-Rached and Daniel Olive are co-senior authors.
Electronic supplementary material The online version of this article (doi:10.1007/s00251-017-0980-z) contains supplementary material, which is available to authorized users. members, a multigene family which is structurally homolog at the extracellular level to the co-signaling B7 family (Linsley et al. 1994 ) and with several members implicated in immune response regulation (Rhodes et al. 2016) . This is the case of Btnl2 regulating the murine T lymphocytes activation and that seems to be a regulator of the intestinal mucosal immunity (Arnett et al. 2007; Nguyen et al. 2006) .
The BTN3 are important regulators of the immune response. Their function, initially suggested by specific stimulations that could inhibit or activate T lymphocytes in function of the antibodies used (Messal et al. 2011; Simone et al. 2010; Yamashiro et al. 2010 ), is currently clearly described for a specific cytotoxic T lymphocytes population, the Vγ9Vδ2 T cells (Harly et al. 2012) . The activation of Vγ9Vδ2 T cells requires the presence of phosphoantigens (pAg), phosphorylated metabolites accumulated in infected and tumor cells (Bonneville and Fournié 2005) . The role of each BTN3 has been investigated through RNA knock down and the use of B30.2 mutants and BTN3A1 has been identified as a key player in this activation which is B30.2 dependent (Harly et al. 2012) . Sandstrom et al. have shown through a structural and functional study that BTN3A1 B30.2 domain binds directly the pAg through a positively charged surface pocket that contains a Histidine residue critical for the binding and which is absent in BTN3A3. When introduced into the B30.2 domain of BTN3A3, the Histidine confers pAgs binding ability and Vγ9Vδ2 T lymphocytes activation (Sandstrom et al. 2014) . Another mechanism of activation has been described: a direct binding of the pAg by the IgV domain of BTN3A1 describing a stimulation model analog to the classical antigen presentation by major histocompatibility complex (MHC) molecules (Vavassori et al. 2013) . Although the exact role of BTN3A2 and 3A3 might be elusive, the RNA knock down experiments by Rhodes et al. have shown that BTN3A2 and 3A3 are implicated in the pAg-induced activation of Vγ9Vδ2 T lymphocytes (Rhodes et al. 2015) .
At the genomic level, the BTN3 are located at the extended HLA class I region on the chromosome 6 within a gene cluster composed of four additional BTN genes: BTN1 and three BTN2 (2A1-2A3). Interestingly, this cluster is plastic in mammals and BTN3 are present in one copy in several non-primate mammals like horses and alpaca (Karunakaran et al. 2014 ) while absent in rodents (Afrache et al. 2012) . Additionally, association studies in human show that genes like BTN3A2 are polymorphic with some SNP that are related to susceptibility to diseases like type 1 diabetes (Viken et al. 2009 ). Similarly, the polymorphism of other BTN such as BTN2A1 is related to susceptibility to type 2 diabetes (Hiramatsu et al. 2011) , chronic kidney disease (Yoshida et al. 2011a; Yoshida et al. 2011b) , metabolic syndrome , dyslipidemia , or myocardial infarction Yoshida et al. 2011c ).
Moreover, a recent study has described the association of the polymorphism of the 3A3-2A1 region with rubella virus-specific cellular immunity following vaccination (Kennedy et al. 2014) . Given the importance of BTN3 for the immune response and their apparent plasticity in mammals and in human populations, we conducted a detailed study of the evolution of these genes in primates and their polymorphism in human populations.
Material and methods

Data for the BTN3 evolution analysis
Sequences used for the analysis were obtained by BLAST search of Bnr,^Best,^Bhtgs,^and Bwgs^databases of the National Center for Biotechnology Information (NCBI).
For the analysis of the BTN3 transcripts, the Gorilla gorilla BTN3A1 sequence was incomplete and was repredicted with the program FGENESH + (Solovyev 2007 ) using the human protein sequence as reference. Similarly, Colobus guereza BTN3 sequences were predicted using the bacterial artificial chromosome (BAC) genomic sequences CH272-166E5 (Genbank accession number AC210406).
BTN3 genomic sequences were obtained from the NCBI BGene^database. The BTN3A1 sequence of G. gorilla and Saimiri boliviensis and the BTN3A3 sequence of Macaca fascicularis were of low quality (large non-sequenced regions) and were excluded. As the New World Monkey group contained only one genomic sequence, the BTN3 evolution could not be studied in this taxonomic group.
Data for the BTN2 evolution analysis
Two of the three BTN2 genes were analyzed (BTN2A3 was excluded as it is a pseudogene) and the sequences were obtained as it was described for BTN3 sequences.
The BTN2A1 transcript sequence of S. boliviensis was incomplete and was re-predicted using genomic sequences similarly to the prediction of the G. gorilla BTN3A1 sequence.
The quality of the two BTN2 genomic sequences of Callithrix jacchus was verified using the transcribed sequences available in the NCBI Best^database and reassembling the genomic sequences generated within the genome sequencing project of C. jacchus by the BWashington University Genome Sequencing Center^and the BBaylor College of Medicine.^For the latter analysis, BLAST searches were made of the NCBI BTrace Archive^database using both BTN2 genomic sequences of C. jacchus: over 170 sequences have been obtained and reassembled with the BSTADEN package^ (Staden et al. 2000) .
Phylogenetic analysis
Nucleotide sequences were aligned using MAFFT (Katoh et al. 2002) and QuickProbs (Gudys and Deorowicz 2014) and corrected manually. Phylogenetic analyses were conducted using three methods: neighbor joining (NJ), parsimony, and maximum likelihood (ML). The NJ phylogenies were performed with MEGA6 (Tamura et al. 2013 ) using the Tamura-Nei method with 500 replicates. For parsimony analyses, PAUP*4.0b10 (Swofford 2001 ) and the tree bisectionreconnection branch swapping algorithm were used with 500 replicates and a heuristic search. RAxML8 (Stamatakis 2014) was used to perform ML phylogenies with the GTR+G model with 500 replicates (rapid bootstrapping).
BTN2 and BTN3 genotyping data in human populations
Exome sequencing data generated by the 1000 Genomes project (Genomes Project et al. 2012) were analyzed for 1683 individuals representing 26 populations. RNA sequencing data generated by the European medical sequencing consortium GEUVADIS (Lappalainen et al. 2013) were downloaded from the website http://www.geuvadis.org/web/geuvadis/RNAseqproject. They correspond to mRNA sequencing data of 295 among the 1683 individuals analyzed for exome data.
The 26 populations were divided into five groups: African origin populations, European origin populations, South Asian origin populations, East Asian origin populations, and populations of the Americas (Table S1 ).
In silico genotyping of BTN2 and BTN3
The genotyping of the five BTN genes analyzed (BTN3A1-3A3, BTN2A1-2A2) was performed as previously described (BTNL2 article). Compared to this approach, an additional analysis was developed for BTN3 genotyping as the first analysis showed the presence of a highly conserved region at the exon encoding the IgV domain. The presence of such a region leads to loss of coverage because the sequences are eliminated to the specificity step since they are not specific to a single gene. In order to verify for each individual, if the low covered or non-covered region contains SNPs or not, a Bcombinedâ nalysis was performed: it consists in using the sequences BTN3A1, 3A2, and 3A3 for the conserved region to identify all the variations. The results of the combined analysis were compared to the result of the individual analysis for each gene and the cases where a variation is present in the combined analysis but absent in the individual analysis were isolated. They correspond to variations missed in the individual analysis. One hundred seventy-two problematic cases were detected: for 35 cases, RNA sequencing data of the same individuals were useful to resolve the genotype. For the remaining 141 genotypes (including 28 genotypes partially resolved: one allele identified), they were resolved statistically (see BTN3 genotypes phasing).
BTN2 and BTN3 genotypes phasing
Genotypes phasing was performed using PHASE 2.1 (Stephens and Scheet 2005; Stephens et al. 2001) . The input files were prepared using SNPtools (Chen et al. 2009 ). Information for associated SNPs was specified using the option -k. Unresolved genotypes in the BTN3 conserved region were determined statistically using B?^in place of the missing position. The reconstruction of allele sequences was done using reference coding sequence of each gene: ENST00000312541 ( B T N 2 A 1 ) , E N S T 0 0 0 0 0 2 4 4 5 1 3 ( B T N 2 A 2 ) , ENST00000289361 (BTN3A1), ENST00000356386 (BTN3A2), and ENST00000244519 (BTN3A3).
Results
Primates have variable number of BTN3 genes
In order to identify the relation between Primates BTN3 sequences, a phylogenetic analysis of coding sequences has been conducted. The three BTN3 genes are present in the Catarrhini group: Hominoids and Old World monkeys ( Fig. 1a) whereas the Prosimians group represented by Otolemur garnettii has only one ortholog and the New World monkeys (NWM) group has two BTN3 genes: one gene ortholog to BTN3A1 and one co-ortholog to 3A2 and 3A3. Thus, the three human BTN3 genes are the result of two successive duplications: a first duplication at the basis of the Simiiformes group gave rise to BTN3A1 and an ancestral sequence of 3A2 and 3A3 and a second duplication at the basis of the Catarrhini group gave rise to 3A2 and 3A3. The domain architecture of the three BTN3 is conserved in the Catarrhini group with two extracellular domains IgV and IgC, a transmembrane domain (TM), and a B30.2 intracellular domain which is absent in 3A2 sequences (Fig. 1e) . The presence of the B30.2 domain in the O. garnettii and the NWM sequences shows that the ancestral structure of the three BTN3 is IgV-IgC-TM-B30.2 and that the B30.2 domain has been lost specifically in BTN3A2 of the Catarrhini group.
The BTN3 IgV domain in Hominoids has undergone several homogenizations
Interestingly, a domain by domain phylogenetic analysis has shown that the BTN3 domains evolved differently ( Fig. 1a-d) . While the phylogenies of the IgC, the B30.2, and the TM (data not shown) domains were compatible with the full-length sequence phylogenies, the phylogeny of the IgV domain shows the presence of paralog groups in human, orangutan, and 
Pan3A1 Oga (Fig. 1b) , which mean that at the IgV domain level, the paralog sequences BTN3A1, 3A2, and 3A3 are more closely related to each other than they are to their orthologs counterparts in a closely related species. Such phylogenetic profile suggests homogenizations of the IgV sequences have occurred in each of these species. The absence of this phylogenetic profile in the OWM group suggests this homogenization is specific to Hominoids. As the NWM group contains only few sequences, the interpretation was difficult even if the presence of a group with BTN3A1 and 3A2/3A3 sequences is compatible with an ancient homogenization (Fig. 1b) . The analysis of the groups present in the IgV phylogeny shows that all Hominoids BTN3A1 sequences are grouped in the BTN3A2/3A3 group (Fig. 1b) , suggesting the homogenizations replaced the BTN3A1 IgV sequences with the IgV sequences of 3A2 or 3A3. In order to identify more precisely the relations between the sequences and the regions homogenized, we extended the analysis to the genomic sequences.
The homogenization targets different regions in the three BTN3 genes
The phylogenetic analysis of the genomic regions (introns/ exons) was performed using variable size windows and reveals different relations between the BTN3 groups depending on the genomic region considered (Suppl. Fig. 1) . Particularly, this analysis shows that BTN3A3 is a chimeric gene resulting from a recombination between the 5′ region of a BTN3A1-like gene and the 3′ region of a BTN3A2-like gene, with a recombination zone located at the untranslated transcribed region (UTR) regions between the positions 4000 and 4025 (Fig. 2a, Suppl. Fig. 1b-c) .
The homogenization detected at the IgV level with the coding sequences analysis was also confirmed. However, it is not limited to the IgVexon but covers a large region. In fact, we detected a specific homogenization between BTN3A2 and BTN3A3 that starts at the 5′ regulatory regions (the second UTR exon) and extends at the 3′ region up to about 100 bp after the IgV exon (Fig. 2b , Suppl. Fig. 1d-g ). A second homogenization region has been detected between BTN3A2 and BTN3A1 that starts at the 5′ side of the IgVexon and continues up to about 200 bp after this exon (Suppl. Fig. 1h-i) . In both cases, the topologies of the phylogenetic trees allow the identification of the homogenization direction and show that BTN3A2 is the donor gene.
The homogenization between BTN3A2 and 3A3 in the Hominoids targets a part of the 5′UTR and the signal peptide (Fig. 2b) leading to highly similar protein sequences at the peptide signal level but divergent from those of BTN3A1 (Fig. 2c) . However, the BTN3A2 and 3A3 sequences of the OWM group, which are not homogenized, are different. Similarly, the homogenized IgV domain between the three BTN3 is conserved in the Hominoids group while the sequences of the OWM group, which are not homogenized, are different (Fig. 2c) . Although the Hominoids and the OWM groups contain the three BTN3 genes, this analysis shows the presence of a homogenization phenomenon targeting specifically the IgV domain in the first but not the second group (Fig. 3 ). We were interested to verify whether such homogenization exists in human populations.
The human BTN3 are polymorphic but with homogenized IgV sequences
To investigate the diversity of human BTN3, we reanalyzed the exomes sequencing data generated by the 1000 Genomes consortium for >1680 individuals representing 26 populations. Careful reconstruction of allelic sequences of the three BTN3 genes reveals that BTN3 are polymorphic with 57, 47, and 61 alleles encoding 33, 23, and 34 allotypes for BTN3A1, 3A2, and 3A3, respectively (Fig. 4a) . However, the majority of allotypes are uncommon with only 8, 5, and 2 allotypes having a frequency >1% in a region of the world for BTN3A1, 3A2, and 3A3, respectively (Fig. 4a-h ).
The comparison of the BTN3 allelic sequences shows that the non-synonymous variations are more concentrated on the IgC domain, in particular for BTN3A2, and on the cytoplasmic region (Fig. 4c-g ). On the contrary, the IgV domain is highly conserved: for example, there are no common allotypes (frequency ≥1% in a region of the world) for BTN3A2 and 3A3 with a variation on the IgV domain (Fig. 4e-h ). Confirming this conservation are the results of the non-synonymous nucleotide diversity analysis for the IgV, IgC, and B30.2 exons between alleles of each gene. We observed a loss of diversity for the IgV exon which is extremely striking between BTN3A1 and 3A2 (Fig. 4b) . Indeed, while BTN3A1 and 3A2 have duplicated tens of millions of years ago, the IgV diversity for 3A1-3A2 pair is of the same order of magnitude as the allelic diversity of each gene and about 3 orders of magnitude lower than the 3A1-3A2 diversity for IgC. Similarly, the other pairs (3A1-3A3 and 3A2-3A3) and 3A1-3A2-3A3 trio have diversity for the IgV lower by Thus, these data show the variation between BTN3A1 and 3A2 at the IgV level is of the same order of magnitude as the allelic variation of each gene for this domain. This result is consistent with an active homogenization in humans of the IgV between these two BTN3. This model is also supported by the existence of several variable positions that are shared between BTN3A1 and 3A2 or 3A3 or represent the reference position in 3A2 and/or 3A3 (Table 1) . This is the case of the position −14 in the signal peptide and 37 and 39 in the IgV which are polymorphic in BTN3A1 but conserved in 3A2 and / or 3A3. The positions −14 and 39 are very common and are carried by alleles in different populations while position 37 is more specific to populations of African origin. Taken together, this strongly suggests that there is always an exchange between genes in this region and that the historical homogenization detected in hominoids still exists in human populations.
The homogenization characterizes also the Primate BTN2 genes evolution
In order to verify if the homogenization observed for BTN3 genes was unique to this group, we preformed the same analyses for BTN2 genes, another phylogenetic group with more than one gene. We first analyzed the relation between the two human BTN2 genes (BTN2A1 and 2A2) and their counterparts in primates and rodent: the two genes were present in the different primate groups while rodents have only one copy of the gene (Fig. 5a and Suppl. Fig. 2 ). The two BTN2 encode for protein with two extracellular domains IgV and IgC separated from a B30.2 cytoplasmic domain with a transmembrane region that differs between the two genes with BTN2A2 having two TM domains in the Simiiformes group. The phylogenetic analysis of coding sequences shows the presence of a homogenization between the two genes in the Prosimians and the NWM groups (Suppl. Fig. 2 ). This result was confirmed by the genomic sequences analysis which illustrates three homogenizations: one at the basis of the Catarrhini group, one in the Prosimians group, and one in the ancestor of the NWM group (Fig. 5b and Suppl. Fig. 3 ). These homogenizations have specifically targeted the exons encoding the signal peptide, the IgV domain, and the B30.2 domain (three homogenizations) but not the exon encoding the TM and a part of the cytoplasmic region (Suppl. Fig. 3) . Interestingly, sequence alignment of the TM region reveals the presence of an important divergence between the two BTN2 at the beginning and at the end of the TM exon. In fact, BTN2A2 contains an insertion of 39 bp at the 5′ side of the exon and a deletion of 54 bp at the 3′ side compared to BTN2A1. This difference leads to a large transmembrane region predicted to contain two TM and a shorter cytoplasmic region upstream B30.2 (Fig. 5c ). Only the divergence at the 3′ side of the TM exon has been conserved between Prosimians BTN2 sequences.
BTN3A1-like
IgV IgC TM B30.2 U-L U BTN3A2-like IgV IgC TM L U U IgV IgC TM B30.2 U-L U
BTN3-like
Duplication Recombination
Primate ancestor
Simiiforme ancestor
Catarrhini ancestor
Similarly to BTN3, the IgV domain has been targeted by several homogenizations in Primates. In order to test if, like for human BTN3, the IgV domain is conserved between the two BTN2, the allelic diversity has been characterized in the same populations as for BTN3 and nucleotide diversity for the IgV, IgC, and B30.2 domains has been estimated for each BTN2 gene as well as for the combination BTN2A1-2A2 (Fig. 5d) . We found that the IgV domain presents the lowest nucleotide diversity among the three domains for the analysis of individual genes. However, the diversity for the 2A1-2A2 analysis for the IgV domain (Fig. 5d) is much higher (between 1 and 3 orders of magnitude) than that observed for the combined analysis between the three BTN3 (Fig. 4b) , despite the fact that the same analysis to the IgC domain produces comparable results for BTN2 and BTN3.
Taken together, these data demonstrate that the homogenization is not limited to BTN3 group but seems to be characteristic of duplicated BTN groups. However, the homogenization is much less pronounced for BTN2 and concerns the extracellular and intracellular region, while for BTN3 it is
Mantled guereza ( ) Colobus guereza BTN3
Human BTN3 Fig. 3 Loss of the diversity at the exon encoding the IgV domain of BTN3. The nucleotide diversity normalized by base pair (bp) was calculated by a window of 100 bp with a step of 25 bp using the program DnaSP version 5.10.1 (Librado and Rozas 2009 
Discussion
Our study of the emergence and diversification of BTN3 in Primates shows that these genes are characterized by recurrent homogenization between paralog genes leading to higher sequence similarity between paralogs than orthologs. This type of evolution called concerted evolution (for review, see (Carson and Scherer 2009; Naidoo et al. 2013) ) is concentrated on a large genomic region from the 5′UTR to the end of the IgV exon. Although the three BTN3 are present in both OWM and Hominoids, the homogenization is observed only in hominoids suggesting the presence of specific evolution constraints on BTN3 in this taxonomic group. Moreover, these constraints seem to be different between the three genes as the homogenization targets distinct regions. In fact, for BTN3A2 and 3A3, the homogenization is concentrated on the 5′UTR region and the exon encoding the signal peptide. The recurrence of this phenomenon in several species (human, orangutan, and gibbon) suggests that strong selection pressure maintains the homogenization of the regulatory elements of the expression of these Fig. 4 The BTN3 are polymorphic in human populations but with an extremely conserved IgV domain. a Summary of alleles and allotypes number for each BTN3. b Values of nucleotide diversity (π) by exon for the alleles of each BTN3. b, e, g Summary of non-synonymous variations for allotypes with a frequency ≥1% in at least one of the regions studied. Allele nomenclature is based on the HLA convention: the first two digits (*xx) correspond to amino acid differences, subsequent digits correspond to synonymous variations. Q denotes alleles with a Bquestionable^struc-ture due to a non-sense mutation. In gray are marked the sequences obtained if the exon with the nonsense mutation is spliced. Abbreviations: LP, leader peptide; IgV, IgV domain; IgC, IgC domain; CR, cytoplasmic region between the TM and the B30.2 domain; TM, transmembrane domain; B30.2, B30.2 domain; n, number of times the allotype is observed; ter, termination codon; NS, nonsynonymous Table 1 List of the variable positions shared between the three genes at the signal peptide region and the IgV domain
The protein positions correspond to the mature protein. Synonymous variations are marked by B-^. In orange are variable positions. In blue are polymorphic positions for which the variation corresponds to the reference in the other gene (e.g., −14, the Histidine is the reference position conserved between 3A2 and 3A3). The percentages correspond to the worldwide frequency of the variable position two genes and cellular distribution of the proteins. However, for the IgV domain, the homogenization concerns the three BTN3 and it is particularly extreme for BTN3A1 and 3A2 in human which explains the apparent conservation of the IgV of the human BTN3. Given that the IgV domain is implicated in the interaction with ligand at the cell surface suggests the three proteins interact with the same ligand.
Interestingly, our data show that BTN3A2 is a donor gene in the historic homogenizations in Hominoids but also in human populations with some variations that are polymorphic in BTN3A1 but conserved in BTN3A2. These data are consistent with a model where BTN3A2 evolves with a partner that varies and then BTN3A2 adaptations arising spread to the other two genes through the homogenization. The major difference between BTN3A2 and the other BTN3 is the absence of the cytoplasmic domain B30.2. The well-known function of the BTN3 is the stimulation of the Vγ9Vδ2 T lymphocytes in presence of phosphoantigens (pAgs), phosphorylated Fig. 1 metabolite accumulated in infected and stressed cells. This stimulation has been shown to be dependent of BTN3A1, and though a direct pAgs presentation to the TCR via the IgV domain has been proposed (Vavassori et al. 2013) , several data are consistent with an indirect presentation implicating the pAgs binding to the B30.2 domain (Harly et al. 2012; Rhodes et al. 2015; Sandstrom et al. 2014) . Previous study has shown that the stimulation of BTN3 with monoclonal antibodies specific of the extracellular region of the three proteins increased the cytokine production by CD4 + and CD8 + T lymphocytes but not by NK cells. This has been explained by the differential expression level of the transcripts of the three genes: while BTN3A1 was majorly expressed in different T cells, BTN3A2 was most expressed in NK cells. Furthermore, stimulation assays using cell lines expressing NKp-30 receptor, implicated in interferon gamma (IFNg) production, and transfected with BTN3A1 or BTN3A2 have shown differential regulation of cytokine production depending on the BTN3 expressed. The co-stimulation of BTN3A2 transfected cells with anti-NKp-30 and anti-BTN3 antibodies decreases the IFNg production while the co-stimulation of BTN3A1 transfected cells increases the IFNg production (Messal et al. 2011) .
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Thus, BTN3A1 and 3A2 seem to have distinct structures and functions but their evolution is extremely correlated at the IgV domain level, typical characteristics of paired receptors. Paired receptors are closely related receptors including inhibitors and activators members and which are encoded by genes organized into clusters (Yamada and McVicar 2008) . They are characterized by very similar extracellular regions with distinct cytoplasmic regions leading to opposite intracellular signals (Lanier 2001). Concerted evolution is responsible for the evolution of certain paired receptors interacting with ligands that are rapidly evolving like the family of KLRC (killer cell lectin-like receptors subfamily C) receptors in Primates implicated in the regulation of the activation and the cytotoxicity of NK cells (Fossum et al. 2011) . Although the BTN3 ligand is not yet identified, these data suggest that depending on the cell types BTN3A2 would be a receptor with opposite cellular effects of those of 3A1 or a decoy receptor interacting with the ligand but with no intracellular signaling. Thus, BTN3A1 and 3A2 would be of potential receptors evolving in pairs in a concerted manner at the level of their IgV domain.
The presence of homogenization between BTN2, which is less recurrent than that observed for BTN3, shows that concerted evolution is not limited to BTN3 but is rather a characteristic of the evolution of BTN groups that duplicated. The major difference between BTN2 at the TM exon which is accompanied by a lack of homogenization in all species requires further investigation to verify the impact of the presence of such a broad membrane region for BTN2A2 and which is associated with a shorter cytoplasmic region upstream of the B30.2 domain, on its expression, structure, and function. Myelin oligodendrocyte glycoprotein (MOG) is a member of the BTN family that has a second TM domain: this domain does not cross through the membrane but is semiintegrated into the lipid bilayer, and lying partially buried in the membrane, exposing the C-terminal part of the protein lacking the B30.2 domain (della Gaspera et al. 1998 ). Thus, the second TM of BTN2A2 could adopt the same conformation or entirely cross the membrane to expose the B30.2 domain at the cell surface. The absence in the galago (O. garnettii) of the difference simple versus double TM, conserved in other primates, suggests that it is not as critical as the difference in the short cytoplasmic region upstream of the B30.2 domain which is conserved in all species studied. This region upstream of the B30.2 domain is present in all BTN having a B30.2 exon (BTN3A2 does not have a B30.2 domain due to an insertion of an Alu repeat sequence interrupting the reading frame (Tazi-Ahnini et al. 1997) ) with a length varying between groups. However, no function has been assigned to this region and the functional data described so far involving the cytoplasmic region are all related to the B30.2 domain (Harly et al. 2012; Sandstrom et al. 2014 ).
In conclusion, we have shown that concerted evolution by homogenization marks the BTN3 history. These data pave new ways for studying the regulation of the BTN3A2 and 3A3 expression or the potential function of BTN3A2 and 3A1 as paired receptors interacting with the same ligand via the IgV domain but with different cellular effects across the cytoplasmic region.
